Microbiota-Gut-Brain Axis and CNS Disorders: Recent Progress and Perspectives on Human Disease summarizes the main findings on gut-brain axis in different types of CNS disorders, providing a complete overview of the field. The content helps unravel the complex interactions of the microbiota-gut-brain-axis in CNS disorders to pave a better understanding of microbiota-mediated pathogenesis, avenues for noninvasive prognosis, and therapeutic possibilities leveraging microbiota-gut-brain-axis modulations. Coverage includes the role of the microbiota-gut-brain axis and gut virome on human diseases including Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Depression and Anxiety, Autism Spectrum Disorder, Multiple Sclerosis, Stroke, and others.
This book will satisfy the urgent need for a broader view of the current associations between gut microbiota alterations and development of CNS disorders, including the use of novel therapeutic approaches for restoring the correct intestinal bacteria content. It is the perfect reference for translational and clinical gut and microbiome researchers tackling the challenges of delivering genes and drugs in a more targeted and efficient manner for the treatment of CNS disorders.
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science Publishing Co Inc
Zielgruppe
Produkt-Hinweis
Broschur/Paperback
Klebebindung
Maße
Höhe: 234 mm
Breite: 191 mm
Dicke: 24 mm
Gewicht
ISBN-13
978-0-443-21680-0 (9780443216800)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Dr. Mishra is working as Professor in Amity Institute of Pharmacy, Gwalior since July 2019. He has around twenty-two years of teaching and research experience. He has more than 140 publications of International and National repute in recent concepts of novel drug delivery systems, localized drug delivery, targeted and controlled drug delivery of nanocarriers/ microparticles for the treatment of breast, colon cancer, and neurodegenerative disorders. Dr. Mishra more than 4100 citations with h- index 36. The total cumulative Impact Factor of his published papers is more than 300 (as per SCOPUS). He has also written more than 25 Books and 45 book chapters in Elsevier, Bentham, Springer and Wiley Publication etc. He has also been granted 3 international patents and 6 Indian patents. Dr. Mishra is recipient of "Distinguished Professor Award? 2019 from DST-NSTMIS, SPAICS, Indore, and M.P. in September 2019. Dr. Mishra has received the "Distinguished Professor Award '' 2021 from Indian Pharmaceutical Association, MP State Branch, Indore. Dr Mishra has received Best Academician Award in the Indian Pharmacy Graduate Association, M.P. State International Conference held on 06th May 2023 at DAVV Auditorium, Indore, India. He is also received one MPCST Project entitled "Dual functional colon- targeted tofacitinib and probiotics loaded microparticles for the treatment of Inflammatory Bowel Disease (2023-24).
Dr. Anoop Kumar is an Assistant Professor in the Department of Pharmacology at Delhi Pharmaceutical Sciences & Research University (DPSRU), India. With a distinguished career, he has previously served as an Assistant Professor and Head at the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, and as Head and Associate Professor at ISF College of Pharmacy, Moga, Punjab. Dr. Kumar has also held research positions at Sun Pharmaceutical Industries Limited and Translational Health Science Institute (THSTI). He earned his Ph.D. from Birla Institute of Technology, Mesra, Ranchi, as a DST INSPIRE Fellow. He is an Associate Editor for Health Sciences Review and Acta Neurologica Scandinavica. His research focuses on drug repurposing, clinical trial meta-analysis, pharmacoeconomics, and pharmacovigilance.
Herausgeber*in
Professor and Head of Department, Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, India
Assistant Professor, Delhi Pharmaceutical Sciences and Research University (DPSRU), India
1. Introduction: An overview of Microbiota-Gut- Brain Axis
2. Role of Microbiota-Gut- Brain Axis in Alzheimer disease and possible interventions
3. Role of Microbiota Gut- Brain axis in Parkinson's disease
4. Role of Microbiota-Gut- Brain Axis in Huntington's disease and possible interventions
5. Role of Microbiota-Gut- Brain Axis in depression and anxiety
6. Role of microbiome- Gut Brain axis in autism spectrum disorder (ASD)
7. Role of Microbiota- Gut brain axis in autoimmunity and Multiple Sclerosis
8. Role of Microbiome Gut- Brain axis in stress
9. Role of Microbiota- Gut Brain Axis in epilepsy and possible interventions
10. Role of Microbiota- Gut Brain Axis in migraine and possible interventions
11. Role of Microbiota- Gut Brain Axis in stroke and possible interventions
12. Role of Microbiota- Gut Brain Axis in brain infections and possible interventions
13. Role of Microbiome Gut- Brain axis in brain disorders
14. Role of GUT microbiota in neuropsychiatric and neurological disorders
15. Role of Microbiota- Gut Brain Axis in Obesity on Cognitive Functions and Mood
16. Role of Microbiota- Gut Brain Axis on Neurotransmitters modulation
17. Role of gut virome and mycobiome in neurological disorders
18. Role of nutraceuticals in neurological diseases
19. Future prospective of Microbiome- Gut brain axis for treatment of CNS disorders
